| scholarly article | Q13442814 |
| P2093 | author name string | G Y Gillespie | |
| C L Gladson | |||
| M A Olman | |||
| V Pijuan-Thompson | |||
| I Z Yacoub | |||
| P2860 | cites work | Factors contributing to increased vascular fibrinolytic activity in mongrel dogs | Q46572677 |
| Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo | Q48088819 | ||
| Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumors. | Q48126931 | ||
| Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors | Q48173866 | ||
| Microglia isolated from rat brain secrete a urokinase-type plasminogen activator | Q48492439 | ||
| Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. | Q52826614 | ||
| Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. | Q55481090 | ||
| Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. | Q55482701 | ||
| Purification and partial characterization of a plasminogen activator inhibitor from the human glioblastoma, U138. | Q55485911 | ||
| Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. | Q55489631 | ||
| Urokinase binding and receptor identification in cultured endothelial cells | Q68261194 | ||
| A comparison between activated protein C and des-1-41-light chain-activated protein C in reactions with type 1 plasminogen activator inhibitor | Q69741837 | ||
| Localization of plasminogen activators in human colon cancer by immunoperoxidase staining | Q69885785 | ||
| Primary structure of single-chain pro-urokinase | Q69974951 | ||
| Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor | Q70311619 | ||
| Major temporal and spatial patterns of gene expression during differentiation of the sea urchin embryo | Q70521522 | ||
| Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis | Q24299135 | ||
| Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA | Q24301748 | ||
| The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes | Q24678932 | ||
| Efficientin vitrosynthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter | Q27861016 | ||
| Secretion of α2-macroglobulin, α2-antiplasmin, and plasminogen activator inhibitor-1 by glioblastoma multiforme in primary organ culture | Q30441481 | ||
| Expression of plasminogen receptors on C6 glioma cells | Q30459369 | ||
| Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator | Q30467362 | ||
| Extracellular proteolysis in the adult murine brain | Q34170437 | ||
| Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells | Q34214125 | ||
| Molecular cloning of cDNA coding for human preprourokinase | Q34379879 | ||
| Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization | Q34563319 | ||
| Novel purification of vitronectin from human plasma by heparin affinity chromatography. | Q34660214 | ||
| Detection and characterization of monoclonal antibodies to platelet membrane proteins | Q36204971 | ||
| Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sites | Q36210510 | ||
| Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma | Q36210862 | ||
| A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase | Q36211634 | ||
| Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease | Q36220992 | ||
| Prevention of metastasis by inhibition of the urokinase receptor | Q36332391 | ||
| Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface | Q36529751 | ||
| Plasminogen activators, tissue degradation, and cancer | Q39476382 | ||
| Biochemical interactions of tumor cells with the basement membrane | Q39503917 | ||
| The human urokinase-plasminogen activator gene and its promoter. | Q40568749 | ||
| The new WHO classification of brain tumours | Q40807273 | ||
| Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness | Q40853039 | ||
| Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells | Q41083036 | ||
| Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases | Q41197936 | ||
| Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro | Q41463431 | ||
| In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase | Q41580011 | ||
| Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer | Q41674938 | ||
| Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines | Q41724882 | ||
| Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin. | Q41725036 | ||
| Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas | Q42131114 | ||
| p1B15: a cDNA clone of the rat mRNA encoding cyclophilin | Q42656764 | ||
| Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression | Q42754658 | ||
| Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor | Q42813159 | ||
| Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation | Q43627851 | ||
| Neonatal subependymal giant cell astrocytoma associated with tuberous sclerosis: MRI, CT, and ultrasound correlation | Q43693552 | ||
| Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines | Q44582678 | ||
| Plasminogen activating enzyme in cultured glioblastoma cells. An immunofluorescence study with monoclonal antibody | Q45037856 | ||
| Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant | Q45854779 | ||
| Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. | Q45975927 | ||
| Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli | Q46154186 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | astrocytoma | Q177755 |
| P304 | page(s) | 1150-1160 | |
| P577 | publication date | 1995-05-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma | |
| P478 | volume | 146 |
| Q37230030 | A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin |
| Q35113892 | Activation of EDTA-resistant gelatinases in malignant human tumors |
| Q37407706 | Anosmin-1 contributes to brain tumor malignancy through integrin signal pathways |
| Q34987834 | Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma |
| Q40874441 | Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells |
| Q41667528 | Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth |
| Q40771280 | Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells |
| Q34102569 | Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta |
| Q55477926 | Inhibitory effects of phenylbutyrate on the proliferation, morphology, migration and invasiveness of malignant glioma cells |
| Q36274412 | Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice. |
| Q38124653 | Invasion as target for therapy of glioblastoma multiforme |
| Q36237406 | Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? |
| Q34178880 | Local anti-angiogenic brain tumor therapies |
| Q34480160 | Molecular biology of nervous system tumors |
| Q34108050 | Multi-agent cytostatic treatment of 'low-grade' gliomas |
| Q35630444 | RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells |
| Q40366505 | Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway |
| Q33641523 | Retracted: Co-Depletion of Cathepsin B and uPAR Induces G0/G1 Arrest in Glioma via FOXO3a Mediated p27Kip1 Upregulation |
| Q33742019 | Retracted: Downregulation of uPAR and Cathepsin B Induces Apoptosis via Regulation of Bcl-2 and Bax and Inhibition of the PI3K/Akt Pathway in Gliomas |
| Q40674540 | Role of integrin alpha(v)beta3 in the early phase of liver metastasis: PET and IVM analyses. |
| Q40793336 | Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion |
| Q55474924 | Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells. |
| Q35773686 | Stage-specific expression of integrin alphaVbeta3 in neuroblastic tumors. |
| Q22009397 | The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contacts |
| Q33921072 | The pathobiology of glioma tumors |
| Q35093788 | Tristetraprolin inhibits the growth of human glioma cells through downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor mRNAs |
| Q41611040 | Urokinase induces receptor mediated brain tumor cell migration and invasion. |
| Q35764470 | Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells |
Search more.